ARCHIVES

Phase III Cyramza Trial Meets OS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer

June 24, 2005

AIDS Cachexia Drug Stabilizes Body Weight, Muscle Mass

March 29, 2013

NCAB Votes Down Dietary Fat Study In women; Proposal highly Recommended By Study Section

September 29, 1989

In Brief: Congressional Action Imminent On Cancer Ac Renewal, Hew Money Bills; Veto Threatened

September 8, 1978

DCT Board Approves Concepts Of Five Contract Recompetitions

October 14, 1983